Ignite Creation Date:
2024-05-06 @ 6:25 PM
Last Modification Date:
2024-10-26 @ 2:48 PM
Study NCT ID:
NCT05659914
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2022-11-22
Brief Title:
Olaparib and Durvalumab MEDI4736 in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations
Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD
Organization:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD
Organization Data
Organization:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD
Class:
OTHER
Study ID:
TTD-20-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |